Podcasts about otsuka pharmaceutical development

Listen to Amica Simmons-Yon, PharmD, PhD and Alyssa Peckham, PharmD, BCPP as they spill the tea on The Holiday Blues with special guest, Bennett Doughty, PharmD, BCPS, BCPP. During this episode, Dr. Doughty discusses mental health during the holiday season. Whether that's a worsening of a pre-existing condition or an emergence of new symptoms, Dr. Doughty walks us through some of the most common experiences and what we can do about them to persevere. Lastly, Dr. Doughty shares some key resources with listeners and where they can read more about this topic! Featuring: • Bennett Doughty, PharmD; Clinical Assistant Professor, Department of Pharmacy Practice, Binghamton School of Pharmacy and Pharmaceutical Sciences • Amica Simmons-Yon, PharmD, PhD; Clinical & Scientific Liaison, OPDC • Alyssa Peckham, PharmD, BCPP; Clinical & Scientific Liaison, OPDC Resources: • PsychU Article - Will Consumers Add Health Services To Their Holiday Shopping List? : bit.ly/3vQ0ZrT • PsychU Community Podcast - Burnout & Managing Stress: bit.ly/3QvHZsb • PsychU Article - Over Half Of Adults In The U.S. Are Considered ‘Lonely': bit.ly/3Gvl6kc • PsychU Article - Severe Loneliness Can Increase Health Care Costs By Over $300 Per Month: bit.ly/3XkNtZg • PsychU Article - Is Loneliness The Overlooked Social Determinant?: bit.ly/3imjTnl • PsychU Video - Digital Technologies For Substance Use Disorder: bit.ly/3WVWyYH • PsychU Downloadable Resource - Substance Use Disorders & Mental Health: bit.ly/3jWP4pr • PsychU Downloadable Resource - Fact Sheet: The Eight Dimensions of Wellness: bit.ly/3XkNQ66 • PsychU Resource Library - Suicide Awareness: bit.ly/3XkNRHc Disclaimers: Bennett Doughy, PharmD is a paid consultant of Otsuka Pharmaceutical Development & Commercialization, Inc Amica Simmons-Yon & Alyssa Peckham are employees of Otsuka Pharmaceutical Development & Commercialization, Inc. PsychU is supported by Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC) and Otsuka America Pharmaceutical, Inc. (OAPI). Specific PsychU programs may be supported by OPDC, OAPI and other committed supporters of the mental health treatment community. The opinions expressed by PsychU's contributors are their own and are not endorsed or recommended by PsychU or its sponsor or the sponsors of the specific PsychU program in which such opinions are expressed. The information provided through PsychU is intended for the educational benefit of mental health care professionals and others who support mental health care. It is not intended as, nor is it a substitute for, medical care, advice, or professional diagnosis. Health care professionals should use their independent medical judgement when reviewing PsychU's educational resources. Users seeking medical advice should consult with a health care professional. No CME or CEU credits are available through any of the resources provided by PsychU. Some of the contributors may be paid consultants for OPDC and OAPI. ©2023 Otsuka Pharmaceutical Development & Commercialization, Inc. All rights reserved.

Listen to Amica Simmons-Yon, PharmD, PhD and Alyssa Peckham, PharmD, BCPP as they spill the tea on The Holiday Blues with special guest, Bennett Doughty, PharmD, BCPS, BCPP. During this episode, Dr. Doughty discusses mental health during the holiday season. Whether that's a worsening of a pre-existing condition or an emergence of new symptoms, Dr. Doughty walks us through some of the most common experiences and what we can do about them to persevere. Lastly, Dr. Doughty shares some key resources with listeners and where they can read more about this topic! Featuring: • Bennett Doughty, PharmD; Clinical Assistant Professor, Department of Pharmacy Practice, Binghamton School of Pharmacy and Pharmaceutical Sciences • Amica Simmons-Yon, PharmD, PhD; Clinical & Scientific Liaison, OPDC • Alyssa Peckham, PharmD, BCPP; Clinical & Scientific Liaison, OPDC Resources: • PsychU Article - Will Consumers Add Health Services To Their Holiday Shopping List? : bit.ly/3vQ0ZrT • PsychU Community Podcast - Burnout & Managing Stress: bit.ly/3QvHZsb • PsychU Article - Over Half Of Adults In The U.S. Are Considered ‘Lonely': bit.ly/3Gvl6kc • PsychU Article - Severe Loneliness Can Increase Health Care Costs By Over $300 Per Month: bit.ly/3XkNtZg • PsychU Article - Is Loneliness The Overlooked Social Determinant?: bit.ly/3imjTnl • PsychU Video - Digital Technologies For Substance Use Disorder: bit.ly/3WVWyYH • PsychU Downloadable Resource - Substance Use Disorders & Mental Health: bit.ly/3jWP4pr • PsychU Downloadable Resource - Fact Sheet: The Eight Dimensions of Wellness: bit.ly/3XkNQ66 • PsychU Resource Library - Suicide Awareness: bit.ly/3XkNRHc Disclaimers: Bennett Doughy, PharmD is a paid consultant of Otsuka Pharmaceutical Development & Commercialization, Inc  Amica Simmons-Yon & Alyssa Peckham are employees of Otsuka Pharmaceutical Development & Commercialization, Inc. PsychU is supported by Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC), Otsuka America Pharmaceutical, Inc. (OAPI), and Lundbeck, LLC – committed supporters of the mental health treatment community. The opinions expressed by PsychU's contributors are their own and are not endorsed or recommended by PsychU or its sponsors. The information provided through PsychU is intended for the educational benefit of mental health care professionals and others who support mental health care. It is not intended as, nor is it a substitute for, medical care, advice, or professional diagnosis. Health care professionals should use their independent medical judgement when reviewing PsychU's educational resources. Users seeking medical advice should consult with a health care professional. No CME or CEU credits are available through any of the resources provided by PsychU. Some of the contributors may be paid consultants for OPDC, OAPI, and / or Lundbeck, LLC.

Listen to Amica Simmons-Yon, PharmD, PhD and Alyssa Peckham, PharmD, BCPP as they spill the tea on Suicide Awareness & Prevention with special guest, Dr. Mauricio Tohen. During this episode, Dr. Tohen highlights the importance of suicide awareness and prevention. He will discuss current trends in mental health and suicide rates, and specific behaviors and triggers that increase risk of suicide especially concerning youth/adolescents and individuals living with bipolar disorder. Our special guest will even spill the tea on where we can find helpful resources on our efforts in Suicide Awareness and Prevention! Dr. Mauricio Tohen is a Distinguished University Professor at the University of New Mexico and the Chairman of the University of New Mexico's Department of Psychiatry and Behavioral Sciences. He has more than 350 publications, 20,000 scientific citations, several books, and prestigious awards to his name. Dr. Tohen has also been recognized as one of the world's leading experts on bipolar disorder on the breadth and depth of his publications, and one of 100 scientists worldwide recognized in the Psychiatry/Psychology category. Featuring: • Mauricio Tohen, MD, DrPH, MBA; Professor & Chairman at the University of New Mexico Health Sciences Center Department of Psychiatry • Amica Simmons-Yon, PharmD, PhD; Clinical & Scientific Liaison, OPDC • Alyssa Peckham, PharmD, BCPP; Clinical & Scientific Liaison, OPDC   Links: PsychU - Suicide Awareness: https://bit.ly/3zUA003 PsychU - Bipolar Disorder: https://bit.ly/3JXPJA8 PsychU - Suicide Prevention Brochure: https://bit.ly/3w0PM8h PsychU - Youth Suicide Prevention - Jonathan Singer: https://bit.ly/3bSaSz4 Home | AFSP: https://afsp.org/ PsychU - Hot Topics: Clinical Questions In Bipolar Disorder (Part 1): https://bit.ly/3QA4eMk PsychU - A Shot For Bipolar I Disorder? Identifying Appropriate Patient Profiles For Maintenance Therapy With Long Acting Injectable Medications: https://bit.ly/3C2HDV0 PsychU - California, Georgia, Indiana, New Jersey, Oklahoma & Virginia Saw Increase In Adolescent Suicides During COVID-19: https://bit.ly/3bT6hN0 PsychU - Children & Adolescents Experiencing Double The Rate Of Depression & Anxiety Due To COVID-19: https://bit.ly/3PmIHWq Mauricio Tohen is a paid consultant of Otsuka Pharmaceutical Development & Commercialization, Inc Amica Simmons-Yon & Alyssa Peckham are employees of Otsuka Pharmaceutical Development & Commercialization, Inc. PsychU is supported by Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC), Otsuka America Pharmaceutical, Inc. (OAPI), and Lundbeck, LLC – committed supporters of the mental health treatment community. The opinions expressed by PsychU's contributors are their own and are not endorsed or recommended by PsychU or its sponsors. The information provided through PsychU is intended for the educational benefit of mental health care professionals and others who support mental health care. It is not intended as, nor is it a substitute for, medical care, advice, or professional diagnosis. Health care professionals should use their independent medical judgement when reviewing PsychU's educational resources. Users seeking medical advice should consult with a health care professional. No CME or CEU credits are available through any of the resources provided by PsychU. Some of the contributors may be paid consultants for OPDC, OAPI, and / or Lundbeck, LLC.

Listen to Amica Simmons-Yon, PharmD, PhD and Alyssa Peckham, PharmD, BCPP as they spill the tea on the impact of racism in the mental healthcare community with special guest, Dr. Gonzalo Gonzalez. As we know, the effects of racism are not confined to patients alone--but also impacts mental health professionals and researchers. During this episode, Dr. Gonzalez will highlight a recent webinar featuring himself and Dr. Napoleon Higgins where they discussed barriers that healthcare professionals experience, including BIPOC and other marginalized groups. Dr. Gonzalez will also discuss his personal experience with racism, where we've been, where we are currently, and strategies the health care and research communities are implementing to address some of these challenges. Dr. Gonzalez currently is a Nephrology Clinical & Scientific Liaison in Medical Affairs at Otsuka Pharmaceutical Development & Commercialization, Inc. He most recently served as a COVID-19 Medical & Scientific Expert for the CDC Foundation and was a leader for Prevention & Control at the City of Detroit Health Department. Featuring: • Gonzalo Gonzalez, DNP, APRN, NP-C Nephrology Clinical & Scientific Liaison, Otsuka Pharmaceutical Development & Commercialization, Inc. • Amica Simmons-Yon, PharmD, PhD; Clinical & Scientific Liaison, OPDC • Alyssa Peckham, PharmD, BCPP; Clinical & Scientific Liaison, OPDC Links: PsychU - The Effects Of Racism On The Mental Healthcare Community: How Marginalized Patients & Providers Are Impacted: https://psychu.org/the-effects-of-racism-on-the-mental-healthcare-community-how-marginalized-patients-providers-are-impacted/ PsychU - Diversity, Equity, & Inclusion: https://bit.ly/3QC4KJZ PsychU - Impact & Trauma Of Racism: https://bit.ly/3phceqc PsychU - Lifespan Impact Of Racism-Related Stress: https://bit.ly/3AhPFHY PsychU - Intergenerational Effects Of Racism: https://bit.ly/3w0ndrI PsychU - The 12 Steps To Inclusivity In Mental Health Services Infographic: https://bit.ly/3zSAXGf PsychU - Call To Action: The Need For Stigma Awareness In Healthcare Professional Education: https://bit.ly/3dludsF Suicide & Black Americans: Statistics, Faith, & Contextual Competence: https://bit.ly/3pgoJSO PsychU - Spotlight On Minority Mental Health Month: A Conversation With Dr. Napoleon B. Higgins Jr.: https://bit.ly/3BYr5x5 Amica Simmons-Yon, Alyssa Peckham, and Gonzalo Gonzalez are employees of Otsuka Pharmaceutical Development & Commercialization, Inc. PsychU is supported by Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC), Otsuka America Pharmaceutical, Inc. (OAPI), and Lundbeck, LLC – committed supporters of the mental health treatment community. The opinions expressed by PsychU's contributors are their own and are not endorsed or recommended by PsychU or its sponsors. The information provided through PsychU is intended for the educational benefit of mental health care professionals and others who support mental health care. It is not intended as, nor is it a substitute for, medical care, advice, or professional diagnosis. Health care professionals should use their independent medical judgement when reviewing PsychU's educational resources. Users seeking medical advice should consult with a health care professional. No CME or CEU credits are available through any of the resources provided by PsychU. Some of the contributors may be paid consultants for OPDC, OAPI, and / or Lundbeck, LLC.

Listen to Amica Simmons-Yon, PharmD, PhD and Alyssa Peckham, PharmD, BCPP as they spill the tea on Minority Mental Health Awareness with special guest, Dr. Carolyn Jones. During this episode, Dr. Jones highlights the importance of mental health awareness in minority communities, educational gaps and needs within the mental health space, and opportunities to reduce stigma amongst minority men for optimal mental wellness. Dr. Jones most recently retired from Otsuka as a Senior Medical Science Liaison after 22 years of providing medical education and resources to healthcare professionals. Currently, Carolyn Jones, PhD stays active and very busy as a Board Member for NAMI Florida, which is the state affiliate of the National Alliance on Mental Illness. Featuring: • Carolyn Jones, PhD; Board Member of NAMI Florida, state affiliate of the National Alliance on Mental Illness • Amica Simmons-Yon, PharmD, PhD; Clinical & Scientific Liaison, OPDC • Alyssa Peckham, PharmD, BCPP; Clinical & Scientific Liaison, OPDC Links: PsychU - Diversity, Equity, & Inclusion: https://bit.ly/3w0UXoL PsychU - The Effects Of Racism On The Mental Healthcare Community: How Marginalized Patients & Providers Are Impacted: https://psychu.org/the-effects-of-racism-on-the-mental-healthcare-community-how-marginalized-patients-providers-are-impacted/ PsychU - 2022 BIPOC Mental Health Month Toolkit: https://bit.ly/3PiPn8g PsychU - Intergenerational Effects Of Racism: https://bit.ly/3AfTVb0 PsychU - Call To Action: The Need For Stigma Awareness In Healthcare Professional Education: https://bit.ly/3C1AbJu PsychU - Suicide & Black Americans: Statistics, Faith, & Contextual Competence: https://bit.ly/3JXoxBp PsychU - Spotlight On Minority Mental Health Month: A Conversation With Dr. Napoleon B. Higgins Jr.: https://bit.ly/3QgLRwi PsychU - Impact & Trauma Of Racism: https://bit.ly/3AkAsGp Carolyn Jones is a paid consultant of Otsuka Pharmaceutical Development & Commercialization, Inc Amica Simmons-Yon & Alyssa Peckham are employees of Otsuka Pharmaceutical Development & Commercialization, Inc. PsychU is supported by Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC), Otsuka America Pharmaceutical, Inc. (OAPI), and Lundbeck, LLC – committed supporters of the mental health treatment community. The opinions expressed by PsychU's contributors are their own and are not endorsed or recommended by PsychU or its sponsors. The information provided through PsychU is intended for the educational benefit of mental health care professionals and others who support mental health care. It is not intended as, nor is it a substitute for, medical care, advice, or professional diagnosis. Health care professionals should use their independent medical judgement when reviewing PsychU's educational resources. Users seeking medical advice should consult with a health care professional. No CME or CEU credits are available through any of the resources provided by PsychU. Some of the contributors may be paid consultants for OPDC, OAPI, and / or Lundbeck, LLC.

Listen to Amica Simmons-Yon, PharmD, PhD and Alyssa Peckham, PharmD, BCPP as they spill the tea on Disaster Psychiatry with special guest, Richard Weisler, MD. During this episode, Dr. Weisler discusses mental health during times of political unrest in light of the current events taking place in Europe. He will highlight an increased need for mental health services during times of disaster, focusing on trauma, post-traumatic stress disorder, and living with uncertainty. Lastly, Dr. Weisler shares key resources with listeners and where they can read more about this topic! Featuring: • Richard Weisler, MD; Psychiatrist, Richard H. Weisler, MD & Associates; Adjunct Professor of Psychiatry, University of North Carolina at Chapel Hill School of Medicine; Adjunct Associate Professor of Psychiatry & Behavioral Sciences, Duke University Medical Center • Amica Simmons-Yon, PharmD, PhD; Clinical & Scientific Liaison, OPDC • Alyssa Peckham, PharmD, BCPP; Clinical & Scientific Liaison, OPDC Links: PsychU Interview | Access To Psychiatric Medications During Times of Natural Disasters & Pandemics: https://bit.ly/3zDarSI Two-part series on “Psychiatry Perspectives On COVID-19” • PsychU Webinar | Part 1 – Impact on Health Care Providers & First Responders And A Path Forward: https://bit.ly/3NQDFBV • PsychU Webinar | Part 2 – Patient Care In A Post-Pandemic World: https://bit.ly/39uB9SD Two-part series on “Emergency Relief Series” • PsychU Webinar | Part 1 – Mental Health Considerations After A Natural Disaster: Clinical Pearls For Those In Nature's Path: https://bit.ly/39wSbzz • PsychU Webinar | Part 2 – Psychiatric Illness Identification & Treatment For Mass Casualty Event Survivors & First Responders: https://bit.ly/3zAaX3R Nine-part series on “After a Natural Disaster or Tragedy” • PsychU Interview | Part 1 – Preparing For & Providing Mental Health Services: https://bit.ly/3xvUZ84 • PsychU Interview | Part 2 – Serving As A Relief Volunteer: https://bit.ly/3zyq8dP • PsychU Interview | Part 3 – Mental Health Awareness Following A Mass Shooting: https://bit.ly/3xQ0jof • PsychU Interview | Part 4 – Engendering Resiliency & Perseverance: https://bit.ly/3zEAU2a • PsychU Interview | Part 5 – Debriefing & Self-Care For Health Care Professionals: https://bit.ly/3xNC6is • PsychU Interview | Part 6 – Psychiatric Distress Presenting In Primary Care: https://bit.ly/3b5ojLn • PsychU Interview | Part 7 – Psychiatry Following A Mass Casualty Incident: https://bit.ly/3xuSTWc • PsychU Interview | Part 8 – Behavioral Health Response Immediately Following A Mass Shooting: https://bit.ly/3MUR5eC • PsychU Interview | Part 9 – Long-Term Behavioral Health Services In Response To A Mass Shooting: https://bit.ly/3xpEg6A Richard Weisler is a paid consultant of Otsuka Pharmaceutical Development & Commercialization, Inc  Amica Simmons-Yon & Alyssa Peckham are employees of Otsuka Pharmaceutical Development & Commercialization, Inc. PsychU is supported by Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC), Otsuka America Pharmaceutical, Inc. (OAPI), and Lundbeck, LLC – committed supporters of the mental health treatment community. The opinions expressed by PsychU's contributors are their own and are not endorsed or recommended by PsychU or its sponsors. The information provided through PsychU is intended for the educational benefit of mental health care professionals and others who support mental health care. It is not intended as, nor is it a substitute for, medical care, advice, or professional diagnosis. Health care professionals should use their independent medical judgement when reviewing PsychU's educational resources. Users seeking medical advice should consult with a health care professional. No CME or CEU credits are available through any of the resources provided by PsychU. Some of the contributors may be paid consultants for OPDC, OAPI, and / or Lundbeck, LLC. US.CORP.X.22.00207

Listen to Amica Simmons-Yon, PharmD, PhD and Alyssa Peckham, PharmD, BCPP as they spill the tea on Decriminalizing Mental Health with special guest, Caroline Fisher-O'Neill, Esq. During this episode, Caroline informs us on the meaning of “criminalization of mental health” so that we can better understand this disparity. She provides us with some examples of disproportionate criminalization and highlights what is currently being done to swing the pendulum in the opposite direction to decriminalize mental health. Excitedly, Caroline lets us know where we can find more resources on this topic! Featuring: Caroline Fisher-O'Neill, Esq.; Director, State Government Affairs, OAPI Caroline Fisher-O'Neill is the East Director for State Government Affairs at Otsuka. Prior to joining this team, nearly 10 years ago, she worked in the Massachusetts State Legislature on health policy. Serving as the General and Health Policy Counsel to the Senate Chair of the Healthcare Finance Committee, and later as Health Policy Counsel to the Speaker of the House, she gained a significant amount of exposure to the challenges inherent in the healthcare policy landscape. In her current role, she works with the GA team to drive open access to treatments and services for Otsuka's patient populations and leads initiatives to support Otsuka's commitment to helping individuals with serious mental illness. She resides in Brooklyn, NY. Amica Simmons-Yon, PharmD, PhD Clinical & Scientific Liaison, Otsuka Pharmaceutical Development and Commercialization, Inc. Alyssa Peckham, PharmD, BCPP Clinical & Scientific Liaison, Otsuka Pharmaceutical Development and Commercialization, Inc. Links: PsychU Interview | Decriminalizing Mental Illness: https://bit.ly/3Nm04WP PsychU Article | Baton Rouge Area Foundation Plans to Create Community Mental Health Diversion Center: https://bit.ly/3PtZGHW PsychU Article | Oregon Law To Decriminalize Drug Use Goes Into Effect, Offering Addiction Treatment Instead Of Incarceration: https://bit.ly/3lnLa6w PsychU Article | Federal Appeals Court Prohibits Arresting Homeless People For Sleeping In Public When Shelter Beds Are Insufficient: https://bit.ly/3Ptv0GF PsychU Article | Connecticut, New Mexico, New York & Virginia Legalized Recreational Use of Marijuana in 2021: https://bit.ly/3FVuTiP Caroline Fisher-O'Neill, Amica Simmons-Yon and Alyssa Peckham are employees of Otsuka America Pharmaceutical, Inc PsychU is supported by Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC), Otsuka America Pharmaceutical, Inc. (OAPI), and Lundbeck, LLC – committed supporters of the mental health treatment community. The opinions expressed by PsychU's contributors are their own and are not endorsed or recommended by PsychU or its sponsors. The information provided through PsychU is intended for the educational benefit of mental health care professionals and others who support mental health care. It is not intended as, nor is it a substitute for, medical care, advice, or professional diagnosis. Health care professionals should use their independent medical judgement when reviewing PsychU's educational resources. Users seeking medical advice should consult with a health care professional. No CME or CEU credits are available through any of the resources provided by PsychU. Some of the contributors may be paid consultants for OPDC, OAPI, and / or Lundbeck, LLC. US.CORP.X.22.00154

Listen to Amica Simmons-Yon, PharmD, PhD and Alyssa Peckham, PharmD, BCPP as they spill the tea on Managed Care & Value-Based Reimbursement with special guest, Madeline Shurtleff, PharmD. During this episode, Dr. Shurtleff highlights the difference between individual health plans and pharmacy benefit managers (PBMs), and how that differs among private insurers versus federal. She also tunes us into the inner workings of the two – namely, how they interact with one another and how decisions are made to deliver your health care. Lastly, Dr. Shurtleff let's us know where we can find more information on managed care topics! Dr. Shurtleff graduated from the University of Rhode Island College of Pharmacy. She started her pharmacy career as a pharmacist at Walgreens before transitioning to managed care. Her managed care experience includes managing utilization management pharmacist teams for various Medicare, Medicaid, and Dual Eligible Special Needs Plan (D-SNP) health plans. As a Managed Market Liaison with Otsuka, she helps to bridge clinical, economic, and disease state information to support better health outcomes for patients. She resides in Phoenix, Arizona. Featuring: • Madeline Shurtleff, PharmD; Managed Market Liaison, OPDC • Amica Simmons-Yon, PharmD, PhD; Clinical & Scientific Liaison, OPDC • Alyssa Peckham, PharmD, BCPP; Clinical & Scientific Liaison, OPDC Links: PsychU Article | Ready, Set, Managed Care! https://bit.ly/3M6Oz4V PsychU Article | Medicaid Managed Care – From 0 To 100: https://bit.ly/3jLOeZv PsychU Interview | Mental Health & COVID-19: Managed Care Perspective: https://bit.ly/3jFWbzi PsychU Article | Collaboration Between Managed Care & Mental Health Staff: Does It Improve Outcomes? https://bit.ly/3xAsUOD PsychU Article | Medicare Managed Care Is On The Increase – At Consumer Request: https://bit.ly/3JRhk41 Madeline Shurtleff, Amica Simmons-Yon, and Alyssa Peckham are employees of Otsuka Pharmaceutical Development & Commercialization, Inc. PsychU is supported by Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC), Otsuka America Pharmaceutical, Inc. (OAPI), and Lundbeck, LLC – committed supporters of the mental health treatment community. The opinions expressed by PsychU's contributors are their own and are not endorsed or recommended by PsychU or its sponsors. The information provided through PsychU is intended for the educational benefit of mental health care professionals and others who support mental health care. It is not intended as, nor is it a substitute for, medical care, advice, or professional diagnosis. Health care professionals should use their independent medical judgement when reviewing PsychU's educational resources. Users seeking medical advice should consult with a health care professional. No CME or CEU credits are available through any of the resources provided by PsychU. Some of the contributors may be paid consultants for OPDC, OAPI, and / or Lundbeck, LLC. US.CORP.X.22.00133

Listen to Amica Simmons-Yon, PharmD, PhD and Alyssa Peckham, PharmD, BCPP as they spill the tea on the hot topic of “medication adherence in Bipolar I Disorder”, with special guest, Dr. Joseph Goldberg. During this episode, Dr. Goldberg discusses the challenges of adherence in BP l Disorder. Our special guest will even spill the tea on where we can find more resources on this topic! Featuring:   Joseph Goldberg, MD  Dr. Joseph Goldberg is a Clinical Professor of Psychiatry at the Icahn School of Medicine at Mount Sinai, is Director of the Affective Disorders Research Program at Silver Hill Hospital in New Canaan, CT, and serves as a Bipolar Section Advisor for PsychU. He has published several books and hundreds of peer-reviewed papers on topics related to the clinical features of bipolar disorder and psychopharmacology. Dr. Goldberg is a Distinguished Fellow of the American Psychiatric Association and has been listed for many years in Best Doctors in America and Castle Connolly's "America's Top Doctors."   Amica Simmons-Yon, PharmD, PhD  Clinical & Scientific Liaison, OPDC   Alyssa Peckham, PharmD, BCPP  Clinical & Scientific Liaison, OPDC   Links: Impact of Adherence on Patients with BP I Disorder | PsychU PsychU | Discussion Of Identifying Profiles Of Patients With Bipolar I Disorder Who Would Benefit From Maintenance Therapy With A Long-Acting Injectable Antipsychotic: https://bit.ly/38cuTyd PsychU | A Shot For Bipolar I Disorder? Identifying Appropriate Patient Profiles For Maintenance Therapy With Long Acting Injectable Medications: https://bit.ly/3iG82wC PsychU | A Look At Adherence In Bipolar Disorder: https://bit.ly/3LgrIn2 PsychU | Treatment Adherence In Mental Health: https://bit.ly/3DgC7wg PsychU | Bipolar Section Advisor Perspective On The COVID-19 Pandemic An Interview With Dr. Joseph Goldberg: https://bit.ly/36SDW6y Research-based Expertise in the Psychopharmacology of Mood Disorders (josephgoldbergmd.com): https://bit.ly/3uD0ssg DBSA - Depression and Bipolar Support Alliance (dbsalliance.org): https://bit.ly/36yaLpD Joseph Goldberg is a paid consultant of Otsuka Pharmaceutical Development & Commercialization, Inc Amica Simmons-Yon & Alyssa Peckham are employees of Otsuka Pharmaceutical Development & Commercialization, Inc. PsychU is supported by Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC), Otsuka America Pharmaceutical, Inc. (OAPI), and Lundbeck, LLC – committed supporters of the mental health treatment community. The opinions expressed by PsychU's contributors are their own and are not endorsed or recommended by PsychU or its sponsors. The information provided through PsychU is intended for the educational benefit of mental health care professionals and others who support mental health care. It is not intended as, nor is it a substitute for, medical care, advice, or professional diagnosis. Health care professionals should use their independent medical judgement when reviewing PsychU's educational resources. Users seeking medical advice should consult with a health care professional. No CME or CEU credits are available through any of the resources provided by PsychU. Some of the contributors may be paid consultants for OPDC, OAPI, and / or Lundbeck, LLC. US.CORP.X.22.00155/

Listen to Amica Simmons-Yon, PharmD, PhD and Alyssa Peckham, PharmD, BCPP as they spill the tea on Psychiatric Advance Directives with special guest, Dr. Leon Ravin. During this episode, Dr. Ravin highlights Psychiatric Advance Directives, its value to the patient at the time of a psychiatric crisis and the impact of the document on the therapeutic alliance and patient outcomes. Dr. Ravin is a Psychiatrist and Statewide Psychiatric Medical Director for the Division of Public and Behavioral Health, State of Nevada. He is an educator and serves in key committees on the National Association of State Mental Health Program Directors, SMI Advisor (an APA and SAMHSA initiative), and the National Psychopharmacology Update. US.CORP.X.22.00092 Featuring: • Leon Ravin, MD; Co-Founder of Progressive Therapeutics • Amica Simmons-Yon, PharmD, PhD; Clinical & Scientific Liaison, OPDC • Alyssa Peckham, PharmD, BCPP; Clinical & Scientific Liaison, OPDC Links: PsychU| Psychiatric Advance Directives Fact Sheet: https://bit.ly/3isYlBB PsychU| Psychiatric Advance Directives – An Introduction: https://bit.ly/36IcsQT PsychU| Psychiatric Advance Directives – A Deep Dive: https://bit.ly/3D3mgRQ PsychU: Psychiatric Advance Directives – Logistic Nuts & Blots: https://bit.ly/3qxCbCL NAMI| Psychiatric Advance Directives: https://bit.ly/3It3Gnj National Resource Center for Psychiatric Advance Directives: https://bit.ly/3542rgv Leon Ravin is a paid consultant of Otsuka Pharmaceutical Development & Commercialization, Inc Amica Simmons-Yon & Alyssa are employees of Otsuka Pharmaceutical Development & Commercialization, Inc. PsychU is supported by Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC), Otsuka America Pharmaceutical, Inc. (OAPI), and Lundbeck, LLC – committed supporters of the mental health treatment community. The opinions expressed by PsychU's contributors are their own and are not endorsed or recommended by PsychU or its sponsors. The information provided through PsychU is intended for the educational benefit of mental health care professionals and others who support mental health care. It is not intended as, nor is it a substitute for, medical care, advice, or professional diagnosis. Health care professionals should use their independent medical judgement when reviewing PsychU's educational resources. Users seeking medical advice should consult with a health care professional. No CME or CEU credits are available through any of the resources provided by PsychU. Some of the contributors may be paid consultants for OPDC, OAPI, and / or Lundbeck, LLC.

Listen to Amica Simmons-Yon, PharmD, PhD and Alyssa Peckham, PharmD, BCPP as they spill the tea on Digital Health & Telepsychiatry with special guest, Dr. Nimish Shah. During this episode, Dr. Shah highlights the pros and cons of telehealth while discussing ways to deliver high quality psychiatric care. Dr. Nimish Shah is a co-founder and provider at Progressive Therapeutics where he has a longstanding commitment to excellence in delivery of patient care. In practice, Dr. Shah teaches the art and science of 21st century mental health care to master's level nursing students from Northeastern University. He also plays a key role at PsychU.org as a clinical expert on the speakers bureau providing resources to the professional community. Featuring: • Nimish Shah, DNP; Co-Founder of Progressive Therapeutics • Amica Simmons-Yon, PharmD, PhD; Clinical & Scientific Liaison, OPDC • Alyssa Peckham, PharmD, BCPP; Clinical & Scientific Liaison, OPDC Links: Progressive Therapeutics allays telehealth security concerns with EHR integration | Healthcare IT News: https://bit.ly/3L4TyU7 Dr. Nimish Shah DNP - PTX: https://bit.ly/3gggdP9 PsychU | Ready For The Digital Health Revolution? Note: It's Not Just Telehealth: https://bit.ly/3gj0uPo PsychU | Privacy & Security In Digital Health: https://bit.ly/3okfOj8 PsychU | Navigating Telepsychiatry In Mental Health Care: A Discussion With A Peer Specialist & A Caregiver: https://bit.ly/3Gm99eo PsychU | Telepsychiatry In Mental Healthcare: Potential Benefits & Guidelines: https://bit.ly/3HoBceE Nimish Shah is a paid consultant of Otsuka Pharmaceutical Development & Commercialization, Inc Amica Simmons-Yon is an employee of Otsuka Pharmaceutical Development & Commercialization, Inc. Alyssa Peckham is an employee of Otsuka Pharmaceutical Development & Commercialization, Inc. PsychU is supported by Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC), Otsuka America Pharmaceutical, Inc. (OAPI), and Lundbeck, LLC – committed supporters of the mental health treatment community. The opinions expressed by PsychU's contributors are their own and are not endorsed or recommended by PsychU or its sponsors. The information provided through PsychU is intended for the educational benefit of mental health care professionals and others who support mental health care. It is not intended as, nor is it a substitute for, medical care, advice, or professional diagnosis. Health care professionals should use their independent medical judgement when reviewing PsychU's educational resources. Users seeking medical advice should consult with a health care professional. No CME or CEU credits are available through any of the resources provided by PsychU. Some of the contributors may be paid consultants for OPDC, OAPI, and / or Lundbeck, LLC.

Listen to Amica Simmons-Yon, PharmD, PhD and Dennis Sholler, PhD as they spill the tea on adherence in schizophrenia with special guest, Kathy Day. During this episode, Kathy Day highlights a recent interview where she discusses the most important factors that impact adherence from a patient and caregiver perspective. Kathy is a caregiver and a mental health advocate; she also plays a key role in PsychU.org as Section Advisor of the Patient & Caregiver Resource Center. Featuring: • Kathy Day, MPA, BA, AA; Patient & Caregiver Section Advisor • Amica Simmons-Yon, PharmD, PhD; Clinical & Scientific Liaison, OPDC • Dennis Sholler, PhD; Clinical & Scientific Liaison, OPDC #mentalhealth PsychU | Patient & Caregiver Resource Center https://bit.ly/3nvh6I2 PsychU | Adherence In Schizophrenia: A Patient & Caregiver Perspective https://bit.ly/3FsNh14 Kathy Day is a paid consultant of Otsuka Pharmaceutical Development & Commercialization, Inc Amica Simmons-Yon is an employee of Otsuka Pharmaceutical Development & Commercialization, Inc. Dennis Sholler is an employee of Otsuka Pharmaceutical Development & Commercialization, Inc. PsychU is supported by Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC), Otsuka America Pharmaceutical, Inc. (OAPI), and Lundbeck, LLC – committed supporters of the mental health treatment community. The opinions expressed by PsychU's contributors are their own and are not endorsed or recommended by PsychU or its sponsors. The information provided through PsychU is intended for the educational benefit of mental health care professionals and others who support mental health care. It is not intended as, nor is it a substitute for, medical care, advice, or professional diagnosis. Health care professionals should use their independent medical judgement when reviewing PsychU's educational resources. Users seeking medical advice should consult with a health care professional. No CME or CEU credits are available through any of the resources provided by PsychU. Some of the contributors may be paid consultants for OPDC, OAPI, and / or Lundbeck, LLC.

Listen to Amica Simmons-Yon, PharmD, PhD and Aneta Fornal, PharmD as they spill the tea about this week's hot topic on insights around Suicide & Black Americans with special guest, Sherry Molock, PhD, LCSW. Dr. Molock is an Associate Professor in the Department of Psychological & Brain Sciences at The George Washington University. Dr. Molock has over 20 years of experience in suicide prevention among Black American communities and is a founding pastor of the Beloved Community Church in Maryland. Join the PsychU Podcast team this week and learn more about Suicide & Black Americans. Featuring: • Amica Simmons-Yon, PharmD, PhD, OPDC CSL • Aneta Fornal, PharmD, OPDC Sr. CSL • Sherry Molock, PhD, M.Div., Associate Professor, George Washington University PsychU | Suicide & Black Americans: Statistics, Faith, & Contextual Competence: https://bit.ly/3jKRQeD PsychU | Suicide Awareness: https://bit.ly/3blQ9Q4 PsychU | Addressing Racial Bias In Health Care: Practice & Organizational Perspectives: https://bit.ly/3vULIFF PsychU | Diversity, Equity, & Inclusion: https://bit.ly/3jN9hLH Home | AFSP: https://bit.ly/3Gth4YB Suicide Prevention Resource Center: https://bit.ly/3w0pOkb Amica Simmons-Yon and Aneta Fornal are employees of Otsuka Pharmaceutical Development & Commercialization, Inc. Sherry Molock is a paid consultant of Otsuka Pharmaceutical Development & Commercialization, Inc. PsychU is supported by Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC), Otsuka America Pharmaceutical, Inc. (OAPI), and Lundbeck, LLC – committed supporters of the mental health treatment community. The opinions expressed by PsychU's contributors are their own and are not endorsed or recommended by PsychU or its sponsors. The information provided through PsychU is intended for the educational benefit of mental health care professionals and others who support mental health care. It is not intended as, nor is it a substitute for, medical care, advice, or professional diagnosis. Health care professionals should use their independent medical judgement when reviewing PsychU's educational resources. Users seeking medical advice should consult with a health care professional. No CME or CEU credits are available through any of the resources provided by PsychU. Some of the contributors may be paid consultants for OPDC, OAPI, and / or Lundbeck, LLC.

Listen to Amica Simmons-Yon, PharmD, PhD and Jacquelyn Canning, PharmD, BCPP as they spill the tea about this week's hot topic in celebration of Pharmacists Month. With special guests Dr.'s Ehret and Silvia, they will discuss what's going on in the Pharmacist Corner and explain the role of pharmacists in depression management. Megan Ehret, PharmD, MS, BCPP is a psychiatric pharmacist and a Professor at the University of Maryland School of Pharmacy. Dr. Ehret is also the Past-President of CPNP and the current Section Editor for the Pharmacist Corner on PsychU. Richard Silvia, PharmD, BCPP is Professor at the Massachusetts College of Pharmacy and Health Sciences. Dr. Silvia maintains a practice site at the Codman Square Health Center, in Dorchester, MA. Join the PsychU Podcast team this week and learn more about the role of Pharmacists in depression management. Featuring: • Amica Simmons-Yon, PharmD, PhD, OPDC MSL • Jacquelyn Canning, PharmD, BCPP, OPDC Sr. MSL • Megan Ehret, PharmD, MS, BCPP • Richard Silvia, PharmD, BCPP #MDD #PharmacistsMonth #PharmD The Role Of The Pharmacist In The Treatment Of Depression - PsychU: https://bit.ly/3peY7ms Suicide Stratification Risk Models & The Role Of Pharmacists In Suicide Education & Prevention - PsychU: https://bit.ly/30xH9VX Pharmacist Corner - PsychU: https://bit.ly/3jdtudn Amica Simmons-Yon and Jacquelyn Canning are employees of Otsuka Pharmaceutical Development & Commercialization, Inc. Megan Ehret and Richard Silvia are paid consultants of Otsuka Pharmaceutical Development & Commercialization, Inc. PsychU is supported by Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC), Otsuka America Pharmaceutical, Inc. (OAPI), and Lundbeck, LLC – committed supporters of the mental health treatment community. The opinions expressed by PsychU's contributors are their own and are not endorsed or recommended by PsychU or its sponsors. The information provided through PsychU is intended for the educational benefit of mental health care professionals and others who support mental health care. It is not intended as, nor is it a substitute for, medical care, advice, or professional diagnosis. Health care professionals should use their independent medical judgement when reviewing PsychU's educational resources. Users seeking medical advice should consult with a health care professional. No CME or CEU credits are available through any of the resources provided by PsychU. Some of the contributors may be paid consultants for OPDC, OAPI, and / or Lundbeck, LLC. US.CORP.X.21.00677

Listen to Amica Simmons-Yon, PharmD, PhD, Jacquelyn Canning, PharmD, BCPP, and Aneta Fornal, PharmD as they spill the tea about this week's hot topic on the mission and insights around Youth Suicide Prevention with special guest, Jonathan Singer, PhD, LCSW. Dr. Singer is an Associate Professor in the School of Social Work at Loyola University Chicago, and he is the founder and host of the award-winning Social Work Podcast. Honorably, Dr. Singer most recently served as the former President of the American Association of Suicidology. Join the PsychU Podcast team this week and learn more about Youth Suicide Prevention. Featuring: • Amica Simmons-Yon, PharmD, PhD, OPDC MSL • Jacquelyn Canning, PharmD, BCPP, OPDC Sr. MSL • Aneta Fornal, PharmD, OPDC Sr. MSL • Jonathan Singer, PhD, LCSW; Associate Professor, Loyola University Chicago Suicide Awareness - PsychU • https://bit.ly/3zTSbRy PsychU | Suicide & Black Americans: Statistics, Faith, & Contextual Competence • https://bit.ly/3m7abTw For Better Or Worse? Bridging The Care Continuum For Mental Health Services In Our New Reality - PsychU • https://bit.ly/3kTc6LT https://socialworkpodcast.com • https://bit.ly/3F3Akvd If you or someone you know is in crisis, please contact the Suicide Prevention Hotline / Lifeline at 1-800-273-TALK (8255), or text the Crisis Text Line at 741-741 Amica Simmons-Yon, Jacquelyn Canning and Aneta Fornal are employees of Otsuka Pharmaceutical Development & Commercialization, Inc. Jonathan Singer is a paid consultant of Otsuka Pharmaceutical Development & Commercialization, Inc. PsychU is supported by Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC), Otsuka America Pharmaceutical, Inc. (OAPI), and Lundbeck, LLC – committed supporters of the mental health treatment community. The opinions expressed by PsychU's contributors are their own and are not endorsed or recommended by PsychU or its sponsors. The information provided through PsychU is intended for the educational benefit of mental health care professionals and others who support mental health care. It is not intended as, nor is it a substitute for, medical care, advice, or professional diagnosis. Health care professionals should use their independent medical judgement when reviewing PsychU's educational resources. Users seeking medical advice should consult with a health care professional. No CME or CEU credits are available through any of the resources provided by PsychU. Some of the contributors may be paid consultants for OPDC, OAPI, and / or Lundbeck, LLC.

Listen to Amica Simmons-Yon, PharmD, PhD and Jacquelyn Canning, PharmD, BCPP as they spill the tea about this week's hot topic: Neuroimaging in Schizophrenia with a special guest, Anissa Abi-Dargham, MD. Dr. Abi-Dargham is the Vice-Chair of Research, Department of Psychiatry & Behavioral Health, Stony Brook University. Join the PsychU podcast team this week and learn more about updates in neuroimaging in schizophrenia and future directions in research. Featuring: • Amica Simmons-Yon, PharmD, PhD, OPDC MSL • Jacquelyn Canning, PharmD, BCPP, OPDC Senior MSL • Anissa Abi-Dargham, MD Neuroimaging Updates In Schizophrenia & The Future Of Precision Medicine: An Interview With Dr. Anissa Abi-Dargham - PsychU https://bit.ly/3AV0b5L Amica Simmons-Yon and Jacquelyn Canning are employees of Otsuka Pharmaceutical Development & Commercialization, Inc. Anissa Abi-Dargham, MD is a paid consultant of Otsuka Pharmaceutical Development & Commercialization, Inc. PsychU is supported by Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC), Otsuka America Pharmaceutical, Inc. (OAPI), and Lundbeck, LLC – committed supporters of the mental health treatment community. The opinions expressed by PsychU's contributors are their own and are not endorsed or recommended by PsychU or its sponsors. The information provided through PsychU is intended for the educational benefit of mental health care professionals and others who support mental health care. It is not intended as, nor is it a substitute for, medical care, advice, or professional diagnosis. Health care professionals should use their independent medical judgement when reviewing PsychU's educational resources. Users seeking medical advice should consult with a health care professional. No CME or CEU credits are available through any of the resources provided by PsychU. Some of the contributors may be paid consultants for OPDC, OAPI, and / or Lundbeck, LLC.

Listen to Amica Simmons-Yon, PharmD, PhD and Jacquelyn Canning, PharmD, BCPP as they spill the tea about this week's hot topic on the vision and mission of NEI to educate psychiatric and neurologic professionals, with a special guest, Sabrina Segal. NEI is a supporting organization of PsychU and was started over 20 years ago by Dr. Stephen Stahl, with the desire to help professionals. Dr. Sabrina Segal is the medical writer for the Neuroscience Education Institute, where she helps educate professionals around the world on novel research. With honor, she is also the host of NEI Podcast. Join the PsychU podcast team this week and learn more about the phenomenal resources that NEI has for the mental health community. Featuring: • Amica Simmons-Yon, PharmD, PhD, OPDC MSL • Jacquelyn Canning, PharmD, BCPP, OPDC MSL • Sabrina Segal, PhD, Medical Writer of NEI   Links: https://psychu.org/ https://www.neiglobal.com/ https://neiglobal.libsyn.com/   Amica Simmons-Yon and Jacquelyn Canning are employees of Otsuka Pharmaceutical Development & Commercialization, Inc. Sabrina Segal is a paid employee of Neuroscience Education Institute (NEI), which is a supporting organization of PsychU PsychU is supported by Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC), Otsuka America Pharmaceutical, Inc. (OAPI), and Lundbeck, LLC – committed supporters of the mental health treatment community. The opinions expressed by PsychU's contributors are their own and are not endorsed or recommended by PsychU or its sponsors. The information provided through PsychU is intended for the educational benefit of mental health care professionals and others who support mental health care. It is not intended as, nor is it a substitute for, medical care, advice, or professional diagnosis. Health care professionals should use their independent medical judgement when reviewing PsychU's educational resources. Users seeking medical advice should consult with a health care professional. No CME or CEU credits are available through any of the resources provided by PsychU. Some of the contributors may be paid consultants for OPDC, OAPI, and / or Lundbeck, LLC.

Listen to Amica Simmons-Yon, PharmD, PhD and Jacquelyn Canning, PharmD, BCPP as they spill the tea about this week's hot topic: STARR Coalition with a special guest, Luke Kramer. Mr. Kramer is the Executive Director of the STARR Coalition which is a forum for the leaders in mental health clinical research, advocacy, treatment, and individuals being served to work together to create a better system of care. Their primary goals are stigma reduction, protection of individual rights, and promotion of research as a viable option in the continuum of care. Join the PsychU podcast team this week and learn more about the STARR Coalition. Featuring: • Amica Simmons-Yon, PharmD, PhD, OPDC MSL • Jacquelyn Canning, PharmD, BCPP, OPDC Senior MSL • Luke Kramer, Executive Director of STARR Coalition The STARR Coalition Seeks To Destigmatize Mental Health Research Through Innovative Initiatives & Programs - PsychU https://bit.ly/3ma25es The STARR Coalition Supports Mental Health Clinical Research By Fostering Goodwill Among Stakeholders & Trust Within Communities - PsychU https://bit.ly/3gaAO7I Amica Simmons-Yon and Jacquelyn Canning are employees of Otsuka Pharmaceutical Development & Commercialization, Inc. Luke Kramer is a consultant of Otsuka Pharmaceutical Development & Commercialization, Inc. PsychU is supported by Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC), Otsuka America Pharmaceutical, Inc. (OAPI), and Lundbeck, LLC – committed supporters of the mental health treatment community. The opinions expressed by PsychU's contributors are their own and are not endorsed or recommended by PsychU or its sponsors. The information provided through PsychU is intended for the educational benefit of mental health care professionals and others who support mental health care. It is not intended as, nor is it a substitute for, medical care, advice, or professional diagnosis. Health care professionals should use their independent medical judgement when reviewing PsychU's educational resources. Users seeking medical advice should consult with a health care professional. No CME or CEU credits are available through any of the resources provided by PsychU. Some of the contributors may be paid consultants for OPDC, OAPI, and / or Lundbeck, LLC.

Listen to Amica Simmons-Yon, PharmD, PhD and Jacquelyn Canning, PharmD, BCPP as they spill the tea about this week's hot topic: Workplace Mental Health with a special guest, Gaurava Agarwal, MD. Dr. Agarwal is an Associate Professor in the Department of Psychiatry and the Behavioral Sciences, Associate Professor of the Department of Medical Education, the Director of Physician Well-Being for Northwestern Medicine's Medical Groups, and Director of Undergraduate Medical Student Education in Psychiatry at Northwestern University Feinberg School of Medicine in Chicago, IL. He also serves as PsychU's Major Depressive Disorder Section Advisor. Join the PsychU podcast team this week and learn more about Workplace Mental Health. Featuring: • Amica Simmons-Yon, PharmD, PhD, OPDC MSL • Jacquelyn Canning, PharmD, BCPP, OPDC Senior MSL • Gaurava Agarwal, MD PsychU Major Depressive Disorder Section https://bit.ly/2VTXW3L Building Better Beings: PsychU Supporting Organizations Share Wellness Strategies - PsychU https://bit.ly/3z9rKrz The Impact Of Pandemics On Well-being: Implications For Healthcare Systems & Providers - PsychU https://bit.ly/3gcMas1 Managing Mental Health During & In The Aftermath Of A Pandemic: Positive Changes From The Current Epidemic - PsychU https://bit.ly/3jWNEYu Amica Simmons-Yon and Jacquelyn Canning are employees of Otsuka Pharmaceutical Development & Commercialization, Inc. Gaurava Agarwal is a paid consultant of Otsuka Pharmaceutical Development & Commercialization, Inc. PsychU is supported by Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC), Otsuka America Pharmaceutical, Inc. (OAPI), and Lundbeck, LLC – committed supporters of the mental health treatment community. The opinions expressed by PsychU's contributors are their own and are not endorsed or recommended by PsychU or its sponsors. The information provided through PsychU is intended for the educational benefit of mental health care professionals and others who support mental health care. It is not intended as, nor is it a substitute for, medical care, advice, or professional diagnosis. Health care professionals should use their independent medical judgement when reviewing PsychU's educational resources. Users seeking medical advice should consult with a health care professional. No CME or CEU credits are available through any of the resources provided by PsychU. Some of the contributors may be paid consultants for OPDC, OAPI, and / or Lundbeck, LLC.

Listen to Amica Simmons-Yon, PharmD, PhD and Jacquelyn Canning, PharmD, BCPP as they spill the tea about this week's hot topic on the vision, mission, and initiatives of Mental Health America with a special guest, America Paredes. Ms. Paredes is the Vice President of Partnerships & Community Outreach at Mental Health America, with more than 20 years of field experience. In her current role, she leads the development and cultivation of strategic alliances to leverage MHA's expertise and forward-thinking of the Before Stage 4 philosophy. MHA's work is driven by its commitment to promote mental health as a critical part of overall wellness. Join the PsychU podcast team this week and learn more about the phenomenal initiatives that MHA has for the community. Featuring: • Amica Simmons-Yon, PharmD, PhD, OPDC MSL • Jacquelyn Canning, PharmD, BCPP, OPDC MSL • America Paredes, VP of Partners & Community Outreach at MHA Mental Health Awareness Month 2021 Toolkit - PsychU: https://bit.ly/3yMe45k National Certified Peer Specialists (NCPS) - PsychU: https://bit.ly/3m4GGTU Mental Health America | Homepage | Mental Health America (mhanational.org): https://bit.ly/3AEIFlR In the Open Podcast | Mental Health America (mhanational.org): https://bit.ly/37BZHVv   Amica Simmons-Yon and Jacquelyn Canning are employees of Otsuka Pharmaceutical Development & Commercialization, Inc. Alison Carroll is a paid employee of Mental Health America organization, which is a supporting organization of PsychU PsychU is supported by Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC), Otsuka America Pharmaceutical, Inc. (OAPI), and Lundbeck, LLC – committed supporters of the mental health treatment community. The opinions expressed by PsychU's contributors are their own and are not endorsed or recommended by PsychU or its sponsors. The information provided through PsychU is intended for the educational benefit of mental health care professionals and others who support mental health care. It is not intended as, nor is it a substitute for, medical care, advice, or professional diagnosis. Health care professionals should use their independent medical judgement when reviewing PsychU's educational resources. Users seeking medical advice should consult with a health care professional. No CME or CEU credits are available through any of the resources provided by PsychU. Some of the contributors may be paid consultants for OPDC, OAPI, and / or Lundbeck, LLC.

Topics to be discussed: 1. What is racial trauma, and does it show up in the workplace amongst our providers? 2. As a Black professional yourself, what challenges do Black MH providers face in the workplace and how does it impact the providers mental health? 3. What are the best strategies for Black providers to use when they encounter racial trauma and workplace stress? 4. What can organizations and employers do to provide support to Black MH providers who experience workplace stress or trauma? 5. What resources do you want to highlight on PsychU? Listen to Amica Simmons-Yon, PharmD, PhD and Jacquelyn Canning, PharmD, BCPP as they spill the tea about this week's hot topic: Racial Trauma in the Workplace with a special guest, Kirby Patmon Williams, PMHNP-BC. Mrs. Williams is a psychiatric nurse practitioner at RBHA in Richmond, VA. She mentors graduate nursing students at various universities across the country and is an adjunct professor at VCU. Kirby is a current member of the American Psychiatric Nurses Association (APNA) and is the founder of the Black PMHNP Collective of Virginia. Join the PsychU podcast team this week and learn more about addressing stress and racial trauma to improve workplace mental health. Featuring: • Amica Simmons-Yon, PharmD, PhD, OPDC MSL • Jacquelyn Canning, PharmD, BCPP, OPDC MSL • Kirby Patmon Williams, MSN, PMHNP-BC Addressing Racial Bias In Health Care: Practice & Organizational Perspectives - PsychU https://bit.ly/2VNLVwB Impact & Trauma Of Racism - PsychU https://bit.ly/3scOEvl Take A Stand On Racial Injustice: Perspectives From Mental Health Experts In Advocacy And Psychiatric Health Care - PsychU https://bit.ly/3sb9D1r Kirby Patmon Williams is a paid consultant of Otsuka Pharmaceutical Development & Commercialization, Inc. Amica Simmons-Yon and Jacquelyn Canning are employees of Otsuka Pharmaceutical Development & Commercialization, Inc. PsychU is supported by Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC), Otsuka America Pharmaceutical, Inc. (OAPI), and Lundbeck, LLC – committed supporters of the mental health treatment community. The opinions expressed by PsychU's contributors are their own and are not endorsed or recommended by PsychU or its sponsors. The information provided through PsychU is intended for the educational benefit of mental health care professionals and others who support mental health care. It is not intended as, nor is it a substitute for, medical care, advice, or professional diagnosis. Health care professionals should use their independent medical judgement when reviewing PsychU's educational resources. Users seeking medical advice should consult with a health care professional. No CME or CEU credits are available through any of the resources provided by PsychU. Some of the contributors may be paid consultants for OPDC, OAPI, and / or Lundbeck, LLC.

Listen to Amica Simmons-Yon, PharmD, PhD and Jacquelyn Canning, PharmD, BCPP as they spill the tea about this week's hot topic: PsychU Nurses Corner with a special guest, Sara Jones, PhD, APRN, PMHNP-BC, FAANP. Dr. Jones is a psychiatric nurse practitioner and teaches as a tenured professor of nursing at University of Arkansas. She also owns her own practice in Little Rock and serves as a section advisor for PsychU Nurses Corner. Join the PsychU podcast team this week and learn more about psychiatric nursing and PsychU Nurses Corner. Featuring: • Amica Simmons-Yon, PharmD, PhD, OPDC MSL • Jacquelyn Canning, PharmD, BCPP, OPDC MSL • Sara Jones, PhD, APRN, PMHNP-BC, FAANP PsychU Nurses Corner https://bit.ly/32VKGew PsychU Nurses Corner Pearls for Practice: Self Injury, Stigma, & Safety https://bit.ly/3gIpWPJ PsychU Nurses Corner Pearls for Practice: Insomnia https://bit.ly/3vkHd5C PsychU Nurses Corner Pearls for Practice: Women's Mental Health and Wellness https://bit.ly/3xBhGXZ Disclaimers Amica Simmons-Yon and Jacquelyn Canning are employees of Otsuka Pharmaceutical Development & Commercialization, Inc. Sara Jones is a paid consultant of Otsuka Pharmaceutical Development & Commercialization, Inc. PsychU is supported by Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC), Otsuka America Pharmaceutical, Inc. (OAPI), and Lundbeck, LLC – committed supporters of the mental health treatment community. The opinions expressed by PsychU's contributors are their own and are not endorsed or recommended by PsychU or its sponsors. The information provided through PsychU is intended for the educational benefit of mental health care professionals and others who support mental health care. It is not intended as, nor is it a substitute for, medical care, advice, or professional diagnosis. Health care professionals should use their independent medical judgement when reviewing PsychU's educational resources. Users seeking medical advice should consult with a health care professional. No CME or CEU credits are available through any of the resources provided by PsychU. Some of the contributors may be paid consultants for OPDC, OAPI, and / or Lundbeck, LLC.

Listen to Amica Simmons-Yon, PharmD, PhD, Jacquelyn Canning, PharmD, BCPP, and Hiten Patadia, PharmD as they spill the tea about this week's hot topic: Recovery-Oriented Perspective & Approach (ROPA) with a special guest, Alison Carroll, LCSW-R. Ms. Carroll is a current member and past president of the New York Association of Psychiatric Rehabilitation Services (NYAPRS) Board. She has also served as board member of the New York State Care Management. Join the PsychU podcast team this week and learn more about the impact of a recovery-oriented perspective & approach in behavioral healthcare. Featuring: • Amica Simmons-Yon, PharmD, PhD, OPDC MSL • Jacquelyn Canning, PharmD, BCPP, OPDC MSL • Hiten Patadia, PharmD, OPDC MSL • Alison Carroll, LCSW-R A Recovery-Oriented Perspective & Approach To Behavioral Health Care (ROPA): A Glossary Discussion https://bit.ly/3cvKXdw A Recovery-Oriented Perspective & Approach To Behavioral Health Care: A Discussion Among A Peer & A Clinical Provider (ROPA Series Part 1) https://bit.ly/3ga9pDD A Recovery-Oriented Perspective & Approach To Behavioral Health Care: A Discussion Among A Peer & A Clinical Provider (ROPA Series Part 2) https://bit.ly/351XSzT Amica Simmons-Yon, Hiten Patadia, and Jacquelyn Canning are employees of Otsuka Pharmaceutical Development & Commercialization, Inc. Alison Carroll is a paid consultant of Otsuka Pharmaceutical Development & Commercialization, Inc. PsychU is supported by Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC), Otsuka America Pharmaceutical, Inc. (OAPI), and Lundbeck, LLC – committed supporters of the mental health treatment community. The opinions expressed by PsychU's contributors are their own and are not endorsed or recommended by PsychU or its sponsors. The information provided through PsychU is intended for the educational benefit of mental health care professionals and others who support mental health care. It is not intended as, nor is it a substitute for, medical care, advice, or professional diagnosis. Health care professionals should use their independent medical judgement when reviewing PsychU's educational resources. Users seeking medical advice should consult with a health care professional. No CME or CEU credits are available through any of the resources provided by PsychU. Some of the contributors may be paid consultants for OPDC, OAPI, and / or Lundbeck, LLC.

Listen to Amica Simmons-Yon, PharmD, PhD and Jacquelyn Canning, PharmD, BCPP as they spill the tea about this week’s hot topic: Depression and Bipolar Support Alliance (DBSA) with a special guest, Hannah Zeller, MSW. Ms. Zeller is a program manager for DBSA and has been instrumental in development and creation of the DBSA Mood CrewTM and more! Join the PsychU podcast team this week and learn more about the programs and resources DBSA has to offer. Featuring: • Amica Simmons-Yon, PharmD, PhD, OPDC MSL • Jacquelyn Canning, PharmD, BCPP, OPDC MSL • Hannah Zeller, MSW Amica Simmons-Yon and Jacquelyn Canning are employees of Otsuka Pharmaceutical Development & Commercialization, Inc. PsychU is supported by Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC), Otsuka America Pharmaceutical, Inc. (OAPI), and Lundbeck, LLC – committed supporters of the mental health treatment community. The opinions expressed by PsychU’s contributors are their own and are not endorsed or recommended by PsychU or its sponsors. The information provided through PsychU is intended for the educational benefit of mental health care professionals and others who support mental health care. It is not intended as, nor is it a substitute for, medical care, advice, or professional diagnosis. Health care professionals should use their independent medical judgement when reviewing PsychU's educational resources. Users seeking medical advice should consult with a health care professional. No CME or CEU credits are available through any of the resources provided by PsychU. Some of the contributors may be paid consultants for OPDC, OAPI, and / or Lundbeck, LLC.

Listen to Amica Simmons-Yon, PharmD, PhD, Jacquelyn Canning, PharmD, BCPP, and Hiten Patadia, PharmD as they spill the tea about this week’s hot topic: “MDD vs Bipolar Disorder.” Join the discussion by learning more about the mechanism of action, potential risks, and potential benefits of cannabis. Take a peek at a few resources on PsychU to learn more about this exciting topic! Resources: Is it MDD or Bipolar Disorder? (Distinguishing Bipolar Series Part 1) Click Here: https://bit.ly/3eV93Ap Addressing Diagnostic Complexities of Bipolar Disorder (Distinguishing Bipolar Series Part 2) Click Here: https://bit.ly/2OOy3i7 PsychU is supported by Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC), Otsuka America Pharmaceutical, Inc. (OAPI), and Lundbeck, LLC – committed supporters of the mental health treatment community. The opinions expressed by PsychU’s contributors are their own and are not endorsed or recommended by PsychU or its sponsors.

Listen to Amica Simmons-Yon, PharmD, PhD, Jacquelyn Canning, PharmD, BCPP, and Hiten Patadia, PharmD as they spill the tea about this week’s hot topic "Substance Abuse Disorder in Psychiatry" with a special guest; Dr. Taca. Dr. Taca is a triple board-certified in Psychiatry, Addiction Medicine, and Preventative Medicine. He is also a distinguished Fellow of the American Society of Addiction Medicine where he served as the president of ASAM - Midwest chapter. Join the PsychU podcast team this week and learn more about his unique practice and the interplay of substance use disorder and psychiatry. Click Here: Challenges & Opportunities For Comorbid Substance Use Disorder & Major Depressive Disorder Click Here: Co-Occurrence Of Substance Use Disorders With Mood Disorders & Psychosis Amica Simmons-Yon, PharmD, PhD, Jacquelyn Canning, PharmD, BCPP, and Hiten Patadia, PharmD are employees of Otsuka Pharmaceutical Development & Commercialization, Inc. PsychU is supported by Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC), Otsuka America Pharmaceutical, Inc. (OAPI), and Lundbeck, LLC – committed supporters of the mental health treatment community. The opinions expressed by PsychU’s contributors are their own and are not endorsed or recommended by PsychU or its sponsors. The information provided through PsychU is intended for the educational benefit of mental health care professionals and others who support mental health care. It is not intended as, nor is it a substitute for, medical care, advice, or professional diagnosis. Health care professionals should use their independent medical judgement when reviewing PsychU's educational resources. Users seeking medical advice should consult with a health care professional. No CME or CEU credits are available through any of the resources provided by PsychU. Some of the contributors may be paid consultants for OPDC, OAPI, and / or Lundbeck, LLC.

Listen to Amica Simmons-Yon, PharmD, PhD, Jacquelyn Canning, PharmD, BCPP, and Hiten Patadia, PharmD as they spill the tea about this week’s hot topic: “Cannabis.” Join the discussion by learning more about the mechanism of action, potential risks, and potential benefits of cannabis. Take a peek at a few resources on PsychU to learn more about this exciting topic! Cannabis: Potential Risks & Benefits In Mental Health – PsychU Click Here: https://bit.ly/3c3K5x4 Amica Simmons-Yon, PharmD, PhD, Jacquelyn Canning, PharmD, BCPP, and Hiten Patadia, PharmD are employees of Otsuka Pharmaceutical Development & Commercialization, Inc. PsychU is supported by Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC), Otsuka America Pharmaceutical, Inc. (OAPI), and Lundbeck, LLC – committed supporters of the mental health treatment community. The opinions expressed by PsychU’s contributors are their own and are not endorsed or recommended by PsychU or its sponsors. The information provided through PsychU is intended for the educational benefit of mental health care professionals and others who support mental health care. It is not intended as, nor is it a substitute for, medical care, advice, or professional diagnosis. Health care professionals should use their independent medical judgement when reviewing PsychU's educational resources. Users seeking medical advice should consult with a health care professional. No CME or CEU credits are available through any of the resources provided by PsychU. Some of the contributors may be paid consultants for OPDC, OAPI, and / or Lundbeck, LLC.

Listen to Amica Simmons-Yon, PharmD, PhD, Jacquelyn Canning, PharmD, BCPP, and Hiten Patadia, PharmD as they spill the tea about this week’s hot topic: “Psychedelics.” Join the discussion by learning more about the mechanism of action, history, and psychedelic-assisted therapies. Take a peek at a few resources on PsychU to learn more about this exciting topic! Psychedelics For The Treatment of Depression: Focus On 5-HT2A - PsychU PsychU is supported by Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC), Otsuka America Pharmaceutical, Inc. (OAPI), and Lundbeck, LLC – committed supporters of the mental health treatment community. The opinions expressed by PsychU’s contributors are their own and are not endorsed or recommended by PsychU or its sponsors.

Listen to Amica Simmons-Yon, PharmD, PhD, Jacquelyn Canning, PharmD, BCPP, and Hiten Patadia, PharmD as they spill the tea about this week’s hot topic: “Social Determinants of Health.” Join the discussion and learn more about SDoH, the domains of SDoH, and why they are important. Addressing Social Determinants: Impacting Health & Wellness Beyond Traditional Medicine (SDoH Series Part 1) https://bit.ly/3bBAsEg How To Build Effective Programs That Meet Payers’ Focus On Social Determinants Of Health: Will The New Codes Pave The Way? (SDoH Series Part 2) https://bit.ly/3svTe6N Understanding The Role Of Social Determinants In Population Health Management https://bit.ly/3uCRWIX Disclaimers Amica Simmons-Yon, PharmD, PhD, Jacquelyn Canning, PharmD, BCPP, and Hiten Patadia, PharmD are employees of Otsuka Pharmaceutical Development & Commercialization, Inc. PsychU is supported by Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC), Otsuka America Pharmaceutical, Inc. (OAPI), and Lundbeck, LLC – committed supporters of the mental health treatment community. The opinions expressed by PsychU’s contributors are their own and are not endorsed or recommended by PsychU or its sponsors. The information provided through PsychU is intended for the educational benefit of mental health care professionals and others who support mental health care. It is not intended as, nor is it a substitute for, medical care, advice, or professional diagnosis. Health care professionals should use their independent medical judgement when reviewing PsychU's educational resources. Users seeking medical advice should consult with a health care professional. No CME or CEU credits are available through any of the resources provided by PsychU. Some of the contributors may be paid consultants for OPDC, OAPI, and / or Lundbeck, LLC

The novel coronavirus pandemic has had a substantial impact on mental health, as well as on its treatment. In the second part of a two-part webinar series on psychiatry perspectives in a post-pandemic world, Richard Weisler, MD, and Allan Chrisman, MD, build upon the dialogue of the pandemic’s impact on health care providers and first responders discussed in “Psychiatry Perspectives On COVID-19: Impact On Health Care Providers & First Responders And A Path Forward (Series 1 of 2)” and shift the focus to discuss the ways in which COVID-19 has affected individuals’ mental health and well-being. They also discuss new innovations and technological approaches to psychiatric patient care and identify effective treatment methods. Moderated by Phillip Lai, PharmD, BCPP, this webinar closes with Drs. Chrisman and Weisler charting a path forward out of the more lingering effects of COVID-19. Allan Chrisman, MD and Richard Weisler, MD are paid consultants of Otsuka Pharmaceutical Development & Commercialization, Inc. Phillip Lai, PharmD, BCPP is a paid employee of Otsuka Pharmaceutical Development & Commercialization, Inc.

Listen to Amica Simmons-Yon, PharmD, PhD, Jacquelyn Canning, PharmD, BCPP, and Hiten Patadia, PharmD as they spill the tea about this week’s hot topic: “Burnout and Managing Stress”. Join the discussion and learn more about the methods of evaluating stress, how chronic stress affects the brain, and management strategies. Avoiding Burnout: Learning To Live & Work Well In Health Care - PsychU • https://www.psychu.org/avoiding-burnout-learning-live-work-well-health-care/?utm_source=podcast&utm_medium=audio&utm_campaign=feb2021_burnout_stress&utm_content=burnout_stress Managing Mental Health During & In The Aftermath Of A Pandemic: Positive Changes From The Current Epidemic - PsychU • https://www.psychu.org/managing-mental-health-during-in-the-aftermath-of-a-pandemic-positive-changes-from-the-current-epidemic/?utm_source=podcast&utm_medium=audio&utm_campaign=feb2021_burnout_stress&utm_content=burnout_stress Balancing Act: Preventing Burnout & Establishing Wellness For Health Care Professionals - PsychU • https://www.psychu.org/balancing-act-preventing-burnout-and-establishing-wellness-for-health-care-professionals/?utm_source=podcast&utm_medium=audio&utm_campaign=feb2021_burnout_stress&utm_content=burnout_stress Balancing Act: Preventing Burnout For Health Care Professionals During The Coronavirus Pandemic & Times Of Crisis - PsychU • https://www.psychu.org/balancing-act-preventing-burnout-for-health-care-professionals-during-the-coronavirus-pandemic-and-times-of-crisis/?utm_source=podcast&utm_medium=audio&utm_campaign=feb2021_burnout_stress&utm_content=burnout_stress Exploring Wellness Strategies In Mental Health - PsychU • https://www.psychu.org/exploring-wellness-strategies-in-mental-health/?utm_source=podcast&utm_medium=audio&utm_campaign=feb2021_burnout_stress&utm_content=burnout_stress The Impact Of Pandemics On Well-being: Implications For Healthcare Systems & Providers - PsychU • https://www.psychu.org/the-impact-of-pandemics-on-well-being-implications-for-healthcare-systems-providers/?utm_source=podcast&utm_medium=audio&utm_campaign=feb2021_burnout_stress&utm_content=burnout_stress Disclaimers Amica Simmons-Yon, PharmD, PhD, Jacquelyn Canning, PharmD, BCPP, and Hiten Patadia, PharmD are employees of Otsuka Pharmaceutical Development & Commercialization, Inc. PsychU is supported by Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC), Otsuka America Pharmaceutical, Inc. (OAPI), and Lundbeck, LLC – committed supporters of the mental health treatment community. The opinions expressed by PsychU’s contributors are their own and are not endorsed or recommended by PsychU or its sponsors. The information provided through PsychU is intended for the educational benefit of mental health care professionals and others who support mental health care. It is not intended as, nor is it a substitute for, medical care, advice, or professional diagnosis. Health care professionals should use their independent medical judgement when reviewing PsychU's educational resources. Users seeking medical advice should consult with a health care professional. No CME or CEU credits are available through any of the resources provided by PsychU. Some of the contributors may be paid consultants for OPDC, OAPI, and / or Lundbeck, LLC. MRC2.CORP.X.05762

Living and working during pandemic is stressful—the uncertainty, the anxiety, the isolation. All take a toll on physical and mental health. But also exerting an effect are the social determinants of health; indeed, their influence may be magnified during this time. In this webinar, Dwayne Mayes, a Peer Support Specialist, and David Larsen, RN, MHA, a Director of Quality Improvement, discuss how the facts of where you were born, where you currently live, how you live, and your access to health care affect your health—and what role peer supports can play to improve outcomes. Dwayne Mayes and David L. Larsen, RN, MHA, are paid consultants for Otsuka Pharmaceutical Development & Commercialization, Inc. Rick Kegler, PharmD, MBA, is a paid employee of Otsuka Pharmaceutical Development & Commercialization, Inc.

Viruses have long been the focus of scientific attention. Over the last several months, this focus has intensified during our fight with the novel human coronavirus SARS-CoV-2. In this webinar, we will provide an overview of viruses and their impact on inflammation, with emphasis on human coronaviruses, including information on hypercytokinemia, also known as the cytokine storm phenomenon. Although COVID-19 preferentially affects the respiratory and cardiovascular systems, there is emerging evidence of neurological sequelae associated with coronaviruses, seen most often in severe cases. Finally, a synopsis of the vaccine-development process and some of the challenges presented therein will be provided. Join neurologist Dr. Gary Pattee as he shares scientific dialogue and perspectives on these topics with pharmacist Dr. Jacquelyn Canning and behavioral neuroscientist Dr. Rachel Self. Gary L. Pattee, MD, is a paid consultant of Otsuka Pharmaceutical Development & Commercialization, Inc. Jacquelyn Canning, PharmD, BCPP, and Rachel Self, PhD, MS, are paid employees of Otsuka Pharmaceutical Development & Commercialization, Inc.

This podcast highlights Kathy Day’s experience as a caregiver for a relative with serious mental illness. Listen in as Ms. Day describes the steps she had taken during the moments her relative was not taking their medication. She also speaks about the times she needed to take her relative for inpatient admissions when they needed extra support. Kathy Day, MPA, currently serves as a caregiver and advocate for a close family member who was diagnosed with schizophrenia in 2010. She also helps to manage online support groups for families coping with mental illness like schizophrenia, bipolar disorder, and major depression. Ms. Day received her MPA from Brandman University. Elizabeth DiNapoli, PhD, is a Medical Science Liaison for Otsuka Pharmaceutical Development & Commercialization, Inc. Dr. DiNapoli earned her PhD from the University of Alabama. Kathy Day is a paid consultant of Otsuka Pharmaceutical Development & Commercialization, Inc. Elizabeth DiNapoli is a paid employee of Otsuka Pharmaceutical Development & Commercialization, Inc. MRC2.CORP.X.04047

The National Committee for Quality Assurance (NCQA) collects information on the performance of health care service delivery from health plans covering more than 191 million people using its proprietary Healthcare Effectiveness Data and Information Set, or HEDIS. One of health care’s most widely used performance improvement tools, HEDIS consists of more than 90 measures over six domains of care. In the behavioral health realm, HEDIS assesses depression screening and follow-up, medication adherence, access, care coordination, opioid overuse, and more.1 Join NCQA speakers Junqing Liu, PhD, and Lyndsey Nguyen as they provide an update on HEDIS behavioral health measures, the expansion of telehealth inclusion in HEDIS measures, the progress of and learnings from quality improvement projects, and relevant behavioral health programs. Junqing Liu, PhD, MSW, and Lyndsey Nguyen are paid consultants of Otsuka Pharmaceutical Development & Commercialization, Inc. Hiten Patadia, PharmD, RPh, is an employee of Otsuka Pharmaceutical Development & Commercialization, Inc. Disclaimer: NCQA owns the content contained in this presentation and such content cannot be reproduced or transmitted without our express written consent of NCQA.

Moderated by Senior Medical Science Liaison Jacque Canning, PharmD, BCPP, this webinar identifies preliminary impacts of COVID-19 on the mental health and well-being of health care providers and first responders. Featuring Allan Chrisman, MD, and Richard Weisler, MD, the webinar covers screening and assessment techniques for identifying psychological stress in individuals on the front lines. Finally, the webinar reviews treatment approaches for health care providers and first responders in a post-pandemic world. Allan Chrisman, MD, and Richard Weisler, MD, are paid consultants for Otsuka Pharmaceutical Development & Commercialization, Inc. Jacquelyn Canning, PharmD, BCPP, is a paid employee of Otsuka Pharmaceutical Development & Commercialization, Inc.

Many Black people in the U.S. are born into a life of trauma, stemming from a history of repression, violence, and injustice. This trauma is not something any of us who have not been Black in America can ever fully understand; it is a very personal, lived experience. In this panel discussion, Napoleon Higgins, MD; Betsy Bennett, PhD; and Kimone James, MD, uncover and examine the adverse psychological and physical impacts of racism. One issue they consider is that of microaggressions in the context of systemic racism. Moderated by Caroline Jones, PhD, Senior Medical Science Liaison for the Otsuka Field Medical Affairs team, the webinar serves as a forum in which the discussants share their experiences of addressing racism and explore what transformational change needs to occur to break the cycle of racism and trauma. Napoleon Higgins, MD; Betsy Bennett, PhD; and Kimone James, MD, are paid consultants of Otsuka Pharmaceutical Development & Commercialization, Inc. Carolyn Jones, PhD, is a paid employee of Otsuka Pharmaceutical Development & Commercialization, Inc.

Joseph Goldberg, MD, and Lisa Goldstone, PharmD, MS, discuss the benefits and limitations of pharmacogenetics testing on current psychiatric practice based on recent evidence from clinical trials as well as their own clinical experience. Although the identification of genetic factors affecting drug safety and efficacy may be beneficial for some patients, pharmacogenetics testing is not currently recommended for routine clinical use. By understanding the scope of information that current pharmacogenetics testing can provide in psychiatry, health care providers can identify ways that this testing can be informative for patients and providers. Joseph Goldberg, MD and Lisa Goldstone, PharmD, MS, are paid consultants of Otsuka Pharmaceutical Development & Commercialization, Inc. Nichole Neugebauer, PhD, is a paid employee of Otsuka Pharmaceutical Development & Commercialization, Inc.

New technologies, changing reimbursements, and corporate consolidations are amongst the many drivers evolving the health care landscape.1 During this webinar archive, the speakers discuss strategies for future sustainability in ever-changing industry. Featuring: • Kimberly Bond Senior Associate, OPEN MINDS • Paul Duck Senior Associate, OPEN MINDS 1Evolving Healthcare Landscape: SHSMD. (n.d.). Retrieved from https://www.shsmd.org/resources/bridging-worlds2.0/evolving-healthcare-landscape. Kimberly Bond brings over thirty years of experience providing behavioral health treatment in the public and community settings to the OPEN MINDS team. She currently serves as the Executive Vice President of Business Development and Marketing. Prior to joining OPEN MINDS, Ms. Bond served concurrently as a Program Coordinator III and Clinical Manager of Adult Services and a Program Coordinator II and Clinical Manager of Recovery Services for the Ozark Guidance Center. In these roles, Ms. Bond was responsible for the administrative and clinical oversight of the adult outpatient and adult intensive mental health services on the Springdale Campus and the adult recovery/co-occurring services, including domestic violence and anger management treatment as well as treatment services for Drug Court. Paul Duck currently serves as a Senior Associate at OPEN MINDS. He brings over 40 years of experience in leadership and management focusing on managed care, health information technology organizations, strategy, business development and market expansion, and customer experience optimization to the OPEN MINDS team. Previously, Mr. Duck has served in roles such as Vice President, Strategy & Development for Beacon Health Options, the Vice President of Business Development for Netsmart Technologies, and Chief Executive Officer for Coastal Orthopedics. Mr. Duck earned his Bachelor of Arts in Business Management from Case Western Reserve University. He earned his Associate of Arts in Electronic Engineering Technology from the Electronic Technology Institute. Speakers are paid consultants to Otsuka Pharmaceutical Development & Commercialization, Inc. PsychU is supported by Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC), Otsuka America Pharmaceutical, Inc. (OAPI), and Lundbeck, LLC – committed supporters of the mental health treatment community. The opinions expressed by PsychU’s contributors are their own and are not endorsed or recommended by PsychU or its sponsors. The information provided through PsychU is intended for the educational benefit of mental health care professionals and others who support mental health care. It is not intended as, nor is it a substitute for, medical care, advice, or professional diagnosis. Health care professionals should use their independent medical judgement when reviewing PsychU's educational resources. Users seeking medical advice should consult with a health care professional. No CME or CEU credits are available through any of the resources provided by PsychU. Some of the contributors may be paid consultants for OPDC, OAPI, and / or Lundbeck, LLC.

In this engaging town hall discussion, Sharon Hicks, MBA, MSW; Steve Remillard, DC; George Braunstein; and Paul Duck—all Senior Associates with OPEN MINDS—address the social determinants of health in the context of COVID-19. How do they affect mental health care service delivery and how does addressing them help meet the needs of a population dealing with the coronavirus pandemic? The panelists also discuss the role that peer support plays in responding to mental health care needs, as well as telehealth and the digital divide. Speakers are paid consultants to Otsuka Pharmaceutical Development & Commercialization, Inc.

Mental health providers detect deterioration for only 21.4% of their patients who experience increased symptom severity.1 Implementing symptom-rating scales to monitor outcomes helps promote clinicians to overcome treatment inertia and change the treatment plan when patients are not responding to treatment. During this PsychU webinar, the speakers identify four levers to optimize clinical and mental health provider performance. Featuring: • Greg Downing, DO, PhD Founder, Innovations Horizons, LLC • Rebecca Plonsky, LICSW Corporate Director of Business Development, Fellowship Health Resources, Inc 1Fortney, J. C., Unützer, J., Wrenn, G., Pyne, J. M., Smith, G. R., Schoenbaum, M., & Harbin, H. T. (2017, February 1). A Tipping Point for Measurement-Based Care. Retrieved from https://www.ncbi.nlm.nih.gov/pubmed/27582237 Greg Downing, DO, PhD, currently serves as the Founder of Innovations Horizons, LLC, a Washington, DC–based consultancy focused on the applications of data in health care delivery transformation initiatives. At Innovation Horizons, LLC, Dr. Downing assists organizations by designing programs, strengthening infrastructure, and enhancing leadership capabilities that are aimed collectively at raising their innovation capacity. Dr. Downing is also Adjunct Professor of Practice at Georgetown University, where he leads the innovation in health care management track. Dr. Downing’s current research interests are in metrics and outcomes-based approaches to health care transformation, including specialty interests in behavioral entrepreneurship and social impact innovation practices. He is the author of more than 80 peer-reviewed publications, as well as multiple books and monographs on biomedical and health care research practices. Rebecca Plonsky currently serves as Corporate Director of Business Development for Fellowship Health Resources, Inc., in addition to being a senior associate at OPEN MINDS. Prior to joining OPEN MINDS, Ms. Plonsky served as the National Vice President of Development for Prospect Integrated Behavioral Health, part of Prospect Alta Hospital Systems, LLC. Based in the Northeast, Ms. Plonsky was responsible for national growth and development of the integrated behavioral health service lines, and she was assigned to lead multiple projects to improve care quality. Ms. Plonsky also served as the Senior Behavioral Health Program Manager for the Rhode Island Executive Office of Health & Human Services. The primary leader for the division, she was responsible for behavioral health Medicaid strategy, program innovation and implementation, policy, and contracting. Disclaimers Speakers are paid consultants to Otsuka Pharmaceutical Development & Commercialization, Inc. PsychU is supported by Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC), Otsuka America Pharmaceutical, Inc. (OAPI), and Lundbeck, LLC – committed supporters of the mental health treatment community. The opinions expressed by PsychU’s contributors are their own and are not endorsed or recommended by PsychU or its sponsors. The information provided through PsychU is intended for the educational benefit of mental health care professionals and others who support mental health care. It is not intended as, nor is it a substitute for, medical care, advice, or professional diagnosis. Health care professionals should use their independent medical judgement when reviewing PsychU's educational resources. Users seeking medical advice should consult with a health care professional. No CME or CEU credits are available through any of the resources provided by PsychU. Some of the contributors may be paid consultants for OPDC, OAPI, and / or Lundbeck, LLC.

Medication adherence has proven challenging for many individuals during the coronavirus pandemic. For all the convenience offered by virtual visits, they make it more difficult to administer injections or assess how patients are responding to medication. Difficulty obtaining refills or necessary lab work can be barriers to medication adherence, as well. Care coordination is especially important now, says Dr. Ehret, who also suggests that providers consider giving patients extra refills when warranted—and check in on patients most at risk for medication nonadherence. Featuring: Megan Ehret, PharmD, MS, BCPP Associate Professor at the University of Maryland School of Pharmacy and PsychU Pharmacist Corner Advisor Joseph Cirrincione, PharmD, MBA Medical Science Liaison, Otsuka Pharmaceutical Development & Commercialization, Inc. Megan Ehret, PharmD, MS, BCPP, is Associate Professor in the Department of Pharmacy Practice & Science at the University of Maryland School of Pharmacy. A board-certified psychiatric pharmacist, she is also PsychU's Pharmacist Corner Section Advisor. Joseph Cirrincione, PharmD, MBA, is Medical Science Liaison for Otsuka Pharmaceutical Development & Commercialization, Inc. Speakers are paid consultants or employees of Otsuka Pharmaceutical Development & Commercialization, Inc. PsychU is supported by Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC), Otsuka America Pharmaceutical, Inc. (OAPI), and Lundbeck, LLC – committed supporters of the mental health treatment community. The opinions expressed by PsychU's contributors are their own and are not endorsed or recommended by PsychU or its sponsors. The information provided through PsychU is intended for the educational benefit of mental health care professionals and others who support mental health care. It is not intended as, nor is it a substitute for, medical care, advice, or professional diagnosis. Health care professionals should use their independent medical judgement when reviewing PsychU's educational resources. Users seeking medical advice should consult with a health care professional. No CME or CEU credits are available through any of the resources provided by PsychU. Some of the contributors may be paid consultants for OPDC, OAPI, and / or Lundbeck, LLC. See omnystudio.com/listener for privacy information. Learn more about your ad choices. Visit megaphone.fm/adchoices

Medication adherence has proven challenging for many individuals during the coronavirus pandemic. For all the convenience offered by virtual visits, they make it more difficult to administer injections or assess how patients are responding to medication. Difficulty obtaining refills or necessary lab work can be barriers to medication adherence, as well. Care coordination is especially important now, says Dr. Ehret, who also suggests that providers consider giving patients extra refills when warranted—and check in on patients most at risk for medication nonadherence. Featuring: Megan Ehret, PharmD, MS, BCPP Associate Professor at the University of Maryland School of Pharmacy and PsychU Pharmacist Corner Advisor Joseph Cirrincione, PharmD, MBA Medical Science Liaison, Otsuka Pharmaceutical Development & Commercialization, Inc. Megan Ehret, PharmD, MS, BCPP, is Associate Professor in the Department of Pharmacy Practice & Science at the University of Maryland School of Pharmacy. A board-certified psychiatric pharmacist, she is also PsychU’s Pharmacist Corner Section Advisor. Joseph Cirrincione, PharmD, MBA, is Medical Science Liaison for Otsuka Pharmaceutical Development & Commercialization, Inc. Speakers are paid consultants or employees of Otsuka Pharmaceutical Development & Commercialization, Inc. PsychU is supported by Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC), Otsuka America Pharmaceutical, Inc. (OAPI), and Lundbeck, LLC – committed supporters of the mental health treatment community. The opinions expressed by PsychU’s contributors are their own and are not endorsed or recommended by PsychU or its sponsors. The information provided through PsychU is intended for the educational benefit of mental health care professionals and others who support mental health care. It is not intended as, nor is it a substitute for, medical care, advice, or professional diagnosis. Health care professionals should use their independent medical judgement when reviewing PsychU's educational resources. Users seeking medical advice should consult with a health care professional. No CME or CEU credits are available through any of the resources provided by PsychU. Some of the contributors may be paid consultants for OPDC, OAPI, and / or Lundbeck, LLC. See omnystudio.com/listener for privacy information.

Medication adherence has proven challenging for many individuals during the coronavirus pandemic. For all the convenience offered by virtual visits, they make it more difficult to administer injections or assess how patients are responding to medication. Difficulty obtaining refills or necessary lab work can be barriers to medication adherence, as well. Care coordination is especially important now, says Dr. Ehret, who also suggests that providers consider giving patients extra refills when warranted—and check in on patients most at risk for medication nonadherence. Speakers are paid consultants or employees of Otsuka Pharmaceutical Development & Commercialization, Inc.

Research has shown that when adding measurement-based care tools to usual care, including psychiatric care, significant improvement in patient outcomes can result. In this podcast, Dwayne Mayes provides his peer support specialist perspective, and Kathy Day, MPA, BA, AA, provides her caregiver perspectives on measurement-based psychiatric care tools. Kathy Day, MPA, BA, AA, and Dwayne Mayes are paid consultants of Otsuka Pharmaceutical Development & Commercialization, Inc. Becky Wong, PharmD, MBA, is a paid employee of Otsuka Pharmaceutical Development & Commercialization, Inc.

In a world of rapidly changing technology, healthcare is evolving to keep up. Pharmacists are in a key position to apply these digital tools. In this webinar presentation, Timothy Aungst, PharmD, and Ravi Patel, PharmD, discuss how technology can improve mental health care. Timothy Aungst, PharmD and Ravi Patel, PharmD are paid consultants of Otsuka Pharmaceutical Development & Commercialization, Inc.

In this webinar, psychiatrist Roger S. McIntyre discusses with Senior Medical Science Liaison Kimberly Lonergan the psychological impact of COVID-19 on those with and without psychiatric illnesses. Dr. McIntyre speaks of the “triple threat” posed by the pandemic. There is the biomedical threat, which sparks anxiety about the health of oneself as well as about that of loved ones. There is the economic uncertainty it has created for many, with employment lost and possible recession looming. And then there is physical distancing, which can increase feelings of isolation and loneliness. This webinar covers the mental health status of individuals during the pandemic, the impact of social media, and rises in suicide rates, which are sensitive to macroeconomic conditions. Dr. McIntyre closes the webinar by offering helpful resources. Speakers are paid consultants to Otsuka Pharmaceutical Development & Commercialization, Inc.

On average, in the United States there is 1 mental health provider for every 536 individuals and providers are not evenly distributed throughout the country. Technological advances in mental health are expanding access to consumers. During the COVID-19 pandemic, the adaptation and utilization of telemedicine services has increased due to social distancing guidelines. In this webinar, hear perspectives from a caregiver and a peer specialist on mental health care delivery, access to telemedicine, and suggestions on how to prepare for a telemedicine visit. Kathy Day, MPA, BA, AA, and Dwayne Mayes are paid consultants of Otsuka Pharmaceutical Development & Commercialization, Inc. Becky Wong, PharmD, MBA, is a paid employee of Otsuka Pharmaceutical Development & Commercialization, Inc.

Pharmacists can monitor medication adherence in several ways, in addition to traditional pill counting. Drs. Megan Ehret and Nathaniel Rickles discuss new innovations in technology that can be used to address medication nonadherence. Megan Ehret, PharmD, MS, BCPP, is the Pharmacist Corner PsychU Section Advisor of PsychU. Ms. Ehret earned her Doctor of Pharmacy from the University of Toledo in Ohio and a Master's in Clinical and Translational Research at the University of Connecticut Health Center. Ms. Ehret completed a Psychiatry Pharmacy Residency at Louis Stokes Cleveland Veterans Affairs Medical Center and a Psychopharmacology and Pharmacogenomics Fellowship at Nova Southeastern University. Nathaniel Rickles, PhD, BCPP is an Associate Professor of Pharmacy Practice, School of Pharmacy at University of Connecticut. Mr. Rickles' primary research interests include improving the roles of community pharmacists to improve medication adherence and safety in vulnerable populations such as those with mental illness and older adults. Mr. Rickles earned his Doctor of Pharmacy from Philadelphia College of Pharmacy & Science. Speakers are paid consultants of Otsuka Pharmaceutical Development & Commercialization, Inc. Disclaimer: The information provided through PsychU is intended for the educational benefit of mental health care professionals and others who support mental health care. It is not intended as, nor is it a substitute for, medical care, advice, or professional diagnosis. Health care professionals should use their independent medical judgement when reviewing PsychU's educational resources. Users seeking medical advice should consult with a health care professional.  Learn more: https://www.psychu.org/  See omnystudio.com/listener for privacy information. Learn more about your ad choices. Visit megaphone.fm/adchoices

Digital health technology can be used in a variety of settings to increase adherence, engage patients, and measure outcomes. This includes within community, hospital, clinical, and retail pharmacies, where pharmacists fill and refill prescriptions, educate patients on medication side effects, review prescriptions for medication contraindications, provide vaccinations and other medical services, manage chronic conditions, and provide medication management services. Many providers, including pharmacists, are adopting digital health solutions to increase their ability to provide efficient and effective care to the patients they serve. In this interview, Dr. Timothy Aungst chats with Dr. Bob Pitasi about the potential opportunities digital health technologies present to the pharmacy profession, including remote enhanced chronic care management, integrated teleservice care, and digitally monitoring patient adherence. Finally, speakers discuss potential barriers to digital health adoption and utilization. Timothy Aungst, Pharm.D., is an Associate Professor of Pharmacy Practice at MCPHS University, in Worcester, Massachusettes. During his post-graduate training, he began writing for multiple companies about mHealth and digital health solutions, with a focus on mobile applications. Since then, Dr. Aungst has conducted research on digital health technologies for pharmacy and published multiple peer review journal articles on the topic. Robert Pitasi, Pharm.D., BCPP, MBA, is a Medical Science Liaison for Otsuka Pharmaceutical Development & Commercialization, Inc.Dr. Pitasi is a paid employee of Otsuka Pharmaceutical Development & Commercialization, Inc. Learn more about the PsychU Community:  https://www.psychu.org/about/  See omnystudio.com/listener for privacy information. Learn more about your ad choices. Visit megaphone.fm/adchoices